Electronic Arts lays off hundreds, cancels ‘Titanfall' game
[NEW YORK] Electronic Arts (EA) is laying off hundreds of workers and cancelling a Titanfall game that was in development at its Respawn Entertainment subsidiary.
Between 300 and 400 positions were eliminated, including around 100 at Respawn, according to a source familiar with the cuts.
'As part of our continued focus on our long-term strategic priorities, we have made select changes within our organisation that more effectively aligns teams and allocates resources in service of driving future growth,' Justin Higgs, a spokesperson for the Redwood City, California-based company, said.
The cancelled project, code-named R7, was an extraction shooter set in the Titanfall universe, according to sources familiar with its development. It was not close to being released.
In a post on social media, Respawn said it 'made the decision to step away from two early-stage incubation projects and make some targeted team adjustments'. The other project referenced in the statement was cancelled earlier this year, the sources said.
Respawn is known for the Apex Legends and Star Wars Jedi titles, and the company said it would continue working on the next Jedi game as well as new seasons and an overhaul for Apex Legends.
Earlier this year, EA reduced its bookings estimate for the fiscal year following the miss of its latest soccer game, EA Sports FC 25. The company also shrunk its subsidiary BioWare following the release of Dragon Age: The Veilguard, which it said missed sales expectations by 50 per cent. BLOOMBERG
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Times
42 minutes ago
- Business Times
Japan curry shops see record bankruptcies as rice prices soar
[TOKYO] A record number of curry shops in Japan went out of business in the past year, as purveyors of one of the country's most beloved dishes took a hit from soaring rice prices. Thirteen curry shops with more than 10 million yen (S$89,345) in debt filed for bankruptcy in the year ending in March – marking a record high for the second consecutive year, according to a report from Tokyo-based research firm Teikoku Databank. The total number of bankruptcies is likely much higher when considering smaller mom-and-pop shops, Teikoku said. Prices of mainstay ingredients in Japanese curry – such as rice, spices, meat and vegetables – have gone up due to a rice shortage, adverse weather and a weak yen, the report said. Higher energy prices have also dented the profits of shop operators. Japanese curry, a thick brown sauce containing meat and vegetables, is usually served on a bed of rice. A basic curry rice dish, a classic comfort food, now costs 365 yen – a record high, according to Teikoku. Prime Minister Shigeru Ishiba's government has been scrambling to combat skyrocketing rice prices in Japan by releasing stockpiles of the staple ahead of a summer election. During the coronavirus pandemic, takeout and delivery orders had fuelled a curry boom – that has now also slowed and hurt sales for curry shops, Teikoku said. BLOOMBERG
Business Times
4 hours ago
- Business Times
Lightstone Ventures, Temasek's ClavystBio co-lead Allay Therapeutics' US$57.5 million Series D funding
[SINGAPORE] United States-based biotechnology company Allay Therapeutics on Thursday (Jun 5) announced it has raised US$57.5 million in a Series D financing round, co-led by biotech venture capital (VC) firm Lightstone Ventures and ClavystBio, a Temasek-linked life sciences venture builder. Participants in the round include the following existing investors: New Enterprise Associates, a US-based VC company; healthcare VC firm Arboretum Ventures; Temasek unit Vertex Holdings' growth-stage VC fund Vertex Growth; Vertex's healthcare fund Vertex Ventures Healthcare; and Australian life sciences VC firm Brandon Capital. New investors who joined the round were US VC firm IPD Capital; Singapore government-backed deep tech investor SGInnovate; as well as EDBI, which operates under SG Growth Capital, the investment platform of the Singapore Economic Development Board and Enterprise Singapore. Drug manufacturer Maruishi Pharmaceutical has expanded its license agreement with Allay Therapeutics to include South Korea and Taiwan, in addition to Japan. As part of this agreement, Maruishi also participated in the Series D round. Meanwhile, HSBC Innovation Banking, which focuses on banking solutions for start-ups, investors and pre-initial public offering companies, also provided additional venture debt financing to Allay Therapeutics. Founded in 2017, Allay Therapeutics, which was incubated by Lightstone Ventures' Singapore fund and The Foundry, focuses on pain relief. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up Its technology is used to create analgesic products that can aid patients with post-surgical pain management and recuperation, reducing the need for opoids and improving patient recovery. The company has teams in the US and Singapore. Funds from the Series D round will support the company's registration trial, which started in February this year and involves 200 participants in multiple US sites. The trial evaluates its product for the treatment of pain after total knee replacement surgery. Results from the trial will be available in the third quarter of 2025.
Business Times
5 hours ago
- Business Times
Asia: Markets wobble as Trump-Xi talks offset by Musk row
[HONG KONG] Asian markets stuttered on Friday as optimism from 'very positive' talks between presidents Donald Trump and Xi Jinping was wiped out by the stunning public row between the US leader and Elon Musk. The much-anticipated discussions between the heads of the world's biggest economies fuelled hopes for an easing of tensions following the US leader's 'Liberation Day' global tariff blitz that targeted Beijing particularly hard. However, investors remained wary after an extraordinary social media row between Trump and billionaire former aide Musk that saw the two trade insults and threats, and sent Wall Street into the red. Wall Street's three main indexes ended down as Musk's electric vehicle company Tesla tanked more than 14 per cent and the president threatened his multibillion-dollar government contracts. Asian equities fluctuated in early business, with some observers suggesting traders were positioning for what could be a volatile start to next week in light of the row and upcoming US jobs data. Hong Kong dropped after three days of strong gains, while Shanghai and Taiwan also retreated. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up Tokyo, Sydney, Singapore and Wellington rose. Chris Weston at Pepperstone said that while the call with Xi was 'seen as a step in the right direction, (it) proved to offer nothing tangible for traders to work with and attention has quickly pushed back to the Trump-Musk war of words'. 'It's all about US nonfarm payrolls from here and is an obvious risk that Asia-based traders need to consider pre-positioning for,' he added. He said there was a risk of Trump sparking market-moving headlines over the weekend given that he is 'now fired up and the risk of him saying something through the weekend that moves markets on the Monday open is elevated'. The US jobs figures, which are due later on Friday, will be closely followed after a below-par reading on private hiring this week raised worries about the labour market and outlook for the world's top economy. They come amid bets that the Federal Reserve is preparing to resume cutting interest rates from September, even as economists warn that Trump's tariffs could reignite inflation. Stephen Innes at SPI Asset Management warned that while poor jobs figures could signal further weakness in the economy, a strong reading could deal a blow to the market. 'In this upside-down market regime, strength can be weakness. A hotter-than-expected (figure) could force traders to price out Fed cuts. That's the paradox in play-where good news on Main Street turns into bad news on Wall Street.' AFP
